CD8A and neoplasm: Surprisingly, no significant differences were observed in the frequency of IFNγ+ or IFNγ+/GzmB+ CD8+ T cells in the brains of any of the groups that received tumors (Supp Fig. 8C-E), and CD8+ T cell counts were highest in untreated tumor-bearing mice (Supp Fig. 8C).